Oncology & Cancer

Finnish researchers identify the cause for LGL leukemia

Researchers of the University of Helsinki, Helsinki University Central Hospital and Institute for Molecular Medicine Finland, have discovered that a mutation in the STAT3 gene is an underlying cause for LGL leukemia. Since ...

Diseases, Conditions, Syndromes

A new way to fight diseases? Stop viruses from stealing nutrients

The immune system has long been touted as the body's primary defense against invading viruses, with the understanding that a strong immune response swiftly knocks out an infection while a weak one allows it to linger, leading ...

HIV & AIDS

Study advances the ability to expose latent HIV

Exposing hidden HIV reservoirs so that they can be cleared is a strategy being tested in efforts to develop therapies to cure the nearly 40 million people worldwide living with HIV. Researchers at the University of North ...

Diseases, Conditions, Syndromes

Researchers make progress toward Epstein-Barr virus vaccine

A research team led by scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) has determined how several antibodies induced by Epstein-Barr virus (EBV), a herpesvirus that causes infectious mononucleosis ...

Diseases, Conditions, Syndromes

Hepatitis C virus survives by hijacking liver microRNA: study

Viral diseases are still one of the biggest challenges to medical science. Thanks to thousands of years of co-evolution with humans, their ability to harness the biology of their human hosts to survive and thrive makes them ...

Medical research

Study demonstrates ability to remove key barrier to an HIV cure

The results of a novel study presented by Emory researchers during the International AIDS Society (IAS) Conference in Brisbane, Australia, have revealed exciting findings in the pursuit of an HIV cure. The study, led by Monica ...

Diabetes

Antibodies reverse type 1 diabetes in new immunotherapy study

Scientists at the University of North Carolina School of Medicine have used injections of antibodies to rapidly reverse the onset of Type I diabetes in mice genetically bred to develop the disease. Moreover, just two injections ...

page 5 from 40